TN5192 |
Tuberosin
|
41347-45-9
|
98%
|
|
Tuberosin shows anti-inflammatory and antioxidant activities.It demonstrated a significantly potent inhibition on yeast α-glucosidase in a dose dependent manner....
|
TN5090 |
Tachioside
|
109194-60-7
|
98%
|
|
Tachioside has antiobesity, antioxidant and α-glucosidase inhibitory activities, it decreases lipid content in 3T3-L1 adipocytes by inhibiting lipogenesis, shows...
|
TN4793 |
Pinoresinol diacetate
|
32971-25-8
|
98%
|
|
Pinoresinol diacetate inhibits the enzyme α-glucosidase in vitro and may therefore act as a hypoglycemic agent.
|
T10751 |
Cefetrizole
|
65307-12-2
|
98%
|
|
Ceftezole is an α-Glucosidase inhibitor (IC50: 2.1 μM; Ki: 0.578 μM).
|
TN5094 |
Tangshenoside I
|
117278-74-7
|
98%
|
|
Tangshenoside I might be a potential bioactive marker related to the hematopoietic and immunologic functions of Codonopsis Radix, which could be recommended as t...
|
TN3745 |
Cyclomusalenone
|
30452-60-9
|
98%
|
|
Cyclomusalenone is a potent α-glucosidase inhibitor.
|
T11749 |
KDM4-IN-2
|
2369607-62-3
|
98%
|
|
KDM4-IN-2 is a potent and selective KDM4/KDM5 dual inhibitor with Kis of 4 and 7 nM for KDM4A and KDM5B, respectively.
|
TN4174 |
Guajadial
|
959860-49-2
|
98%
|
|
Guajadial shows α-glucosidase inhibitory activities significantly and its activity was better than that of Acarbose.Guajadial may act as Selective Estrogen Recep...
|
T16480 |
PF-04991532
|
1215197-37-7
|
98%
|
|
PF-04991532 is an effective, hepatoselective glucokinase activator. It has EC50s of 80 and 100 nM in human and rat, respectively.
|
T6759 |
AP-III-a4
|
1177827-73-4
|
99.90%
|
|
AP-III-a4 (ENOblock) (ENOblock) is the first nonsubstrate analogue inhibitor of enolase with IC50 of 0.576 μM.
|
T36491 |
POMHEX
|
2004714-34-3
|
99.88%
|
|
Pomhex, a cell-permeable potent enolase inhibitor with anticancer activity, is used in the study of cancer lethality.Pomhex, a racemic mixture, is a potent and s...
|
T11741 |
KAN0438757
|
1451255-59-6
|
99.8%
|
|
KAN0438757 is a selective and potent inhibitor of the metabolic kinase PFKFB3 with an IC50 of 0.19 μM.
|
T64320 |
ML251
|
1486482-16-9
|
99.79%
|
|
ML251 is a potent novel nanomolar inhibitor of T. brucei and T. cruzi phosphofructokinase[1]. ML251 inhibits T. brucei PFK (IC50=0.37 μM) and T. cruzi PFK (IC50=...
|
T15159 |
Dorzagliatin
|
1191995-00-2
|
99.74%
|
|
Dorzagliatin (HMS5552) is a dual-acting glucokinase (GK) activator. It also improves glycaemic control and pancreatic β-cell function in type 2 diabetes.
|
T22223 |
3PO
|
18550-98-6
|
99.67%
|
|
3PO is a small-molecule inhibitor of PFKFB3 (IC50: 22.9 μM), inhibiting the proliferation of several human malignant hematopoietic and adenocarcinoma cell lines ...
|
T3312 |
AM-2394
|
1442684-77-6
|
99.58%
|
|
AM-2394 is an effective and specific Glucokinase agonist (GKA, EC50: 60 nM), which catalyzes the phosphorylation of glucose to glucose-6-phosphate. AM-2394(AM239...
|
T3386 |
Kaempferitrin
|
482-38-2
|
99.51%
|
|
Kaempferitrin (Lespenephryl) has antidepressant-like effect related to the serotonergic system, principally 5-HT1A. Kaempferitrin exerts cytotoxic and antitumor ...
|
T3104 |
Globalagliatin
|
1234703-40-2
|
99.41%
|
|
Globalagliatin (LY2608204) has been used in trials studying the treatment of Diabetes Mellitus, Type 2.
|
T26712 |
AZD-1656
|
919783-22-5
|
99.37%
|
|
AZD-1656 is a glucokinase activator (GKA) that can cause dose-limiting hypoglycemia in normal animals used in embryofetal development studies and type 2 diabetes...
|
T19500 |
Palmitelaidic Acid
|
10030-73-6
|
99.36%
|
|
Palmitelaidic Acid (trans-Palmitoleic acid) is one of the most abundant fatty acids in serum and tissue.
|